IMPLANET Announces Its 2024 Financial Calendar
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, today announces its schedule for the publication of financial information for 2024Etats-Unis de son expansion commerciale aux Etats-Unis,.
Event |
Dates*
2023 Full-Year Revenue
January 15, 2024
2023 Full-Year Results
March 5, 2024
2024 First-Quarter Revenue
April 9, 2024
Annual General Meeting
April 25, 2024
2024 First-Half Revenue
July 9, 2024
2024 First-Half Results
September 10, 2024
2024 Third-Quarter Revenue
October 8, 2024
(*) Subject to change. Press releases will be issued after market close.
Upcoming financial publication
- 2023 Full-Year Revenue, on January 15, 2024 after market
About IMPLANET
Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery and distributing medical technology equipment.
Its activity revolves around a comprehensive innovative solution for improving the treatment of spinal pathologies (JAZZ) complemented by the product range offered by Orthopaedic & Spine
Development (OSD), acquired in May 2021 (thoraco-lumbar screws, cages and cervical plates). Implanet’s tried-and-tested orthopedic platform is based on the traceability of its products. Protected
by four families of international patents, JAZZ has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States, the CE mark in Europe and ANVISA approval
in Brazil. In 2022, IMPLANET entered into a commercial, technological and financial partnership with SANYOU MEDICAL, China's second largest medical device manufacturer. IMPLANET employs 43 staff
and recorded a consolidated revenue of €8.0 million in 2022. Based near Bordeaux in France, IMPLANET opened a US subsidiary in Boston in 2013. IMPLANET is listed on the Euronext Growth market in
Paris.
For further information, please visit www.Implanet.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240111331422/en/
The Implanet Stock at the time of publication of the news with a fall of -0,57 % to 0,061EUR on Lang & Schwarz stock exchange (11. Januar 2024, 17:28 Uhr).